A new blood test to detect cancer at an early stage has shown promising results, according to a study, as scientists aim to make the process as common as cholesterol or blood sugar testing.
Researchers from Oxford University say the test, known as TriOx, accurately identified the disease, including in its earliest stages when it is hardest to detect, across six types of cancer: bowel, oesophageal, pancreatic, renal, ovarian and breast.
